A Phase III Trial of External Beam of Radiotherapy +/- Total Androgen Suppression for High Risk Clinically Organ-Confined Prostate Cancer
Latest Information Update: 10 Jan 2022
At a glance
- Drugs Flutamide (Primary) ; Goserelin (Primary) ; Leuprorelin (Primary) ; Antiandrogens; Gonadotropin releasing hormone stimulants
- Indications Prostate cancer
- Focus Therapeutic Use
- 16 Dec 2021 Status changed from active, no longer recruiting to completed.
- 08 Mar 2021 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 06 Jul 2020 Planned End Date changed from 1 Jun 2020 to 1 Dec 2020.